![]() |
|
searchpremium serviceseventsdirectory servicesadvertisingcustomer care |
Archives :: Chem Ideas :: Guest Author
Displaying 1 - 20 of 212 stories.
May 21, 2013
Cambrex completes Charles City facility expansion Cambrex (East Rutherford, NJ) says it has completed the previously announced expansion of the large-scale manufacturing facility at...http://www.chemweek.com/chem_ideas/Guest-Author/Pharmafine-chemicals-roundup-21-May-2013_52199.html May 14, 2013
Ampac Fine Chemicals swings to profit Ampac Fine Chemicals (AFC; Rancho Cordova, CA), a subsidiary of American Pacific (Las Vegas), recorded an operating profit of $3.8 million in its...http://www.chemweek.com/chem_ideas/Guest-Author/Pharmafine-chemicals-roundup-14-May-2013_51978.html May 9, 2013
The need to innovate, to improve existing solutions and create new ones, is essential for the future success of any business. Customers want products and services to be faster...http://www.chemweek.com/chem_ideas/Guest-Author/Creating-an-open-mindset-to-innovate_51881.html May 7, 2013
Teva’s API business reports fall in sales The active pharmaceutical ingredient (API) business of Teva Pharmaceutical Industries (Petaḥ Tiqwa, Israel), recorded a 6.5% fall in...http://www.chemweek.com/chem_ideas/Guest-Author/Pharmafine-chemicals-roundup-7-May_51808.html May 6, 2013
I once led a restructuring project in one of Hoechst Celanese’s largest manufacturing facilities. The project team included multiple people in the facility with an ultimate...http://www.chemweek.com/chem_ideas/Guest-Author/The-true-value-of-a-task_51793.html April 30, 2013
Lonza results in line with expectations Lonza, in its business update announcement for the first quarter of 2013, says that its business performance was solid and in line with...http://www.chemweek.com/chem_ideas/Guest-Author/Pharmafine-chemicals-roundup-30-April_51592.html April 23, 2013
People apply what they know across all aspects of their lives. Some may use negotiation skills honed at the office in parenting at home. Others may apply a team approach from a weekend...http://www.chemweek.com/chem_ideas/Guest-Author/Improv-and-innovation_51388.html April 23, 2013
Hikma to retain injectables business Hikma Pharmaceuticals (London) says it has concluded a review of the strategic options for its global Injectables business and decided that this...http://www.chemweek.com/chem_ideas/Guest-Author/Pharmafine-chemicals-roundup-23-April_51368.html April 16, 2013
FDA’s self-identification process for 2014 begins in May The US FDA says that the generic drug facility self-identification reporting period for fiscal-year 2014 will begin on 1...http://www.chemweek.com/chem_ideas/Guest-Author/Pharmafine-chemicals-roundup-16-April_51203.html April 9, 2013
Teijin acquires 10% stake in Kyorin Holdings Teijin says it has acquired 7.59 million shares, or 10% of the outstanding shares of Kyorin Holdings (Tokyo), from Kyorin’s major...http://www.chemweek.com/chem_ideas/Guest-Author/Pharmafine-chemicals-roundup-9-April_51019.html April 2, 2013
Ferro sells pharma business Ferro has completed the sale of its pharmaceuticals business, Pfanstiehl Laboratories, to private equity firm Med Opportunity Partners (Greenwich, CT)...http://www.chemweek.com/chem_ideas/Guest-Author/Pharmafine-chemicals-roundup-2-April_50886.html March 26, 2013
Private equity firm acquires Micron Technologies Private equity firm Arlington Capital Partners (Washington) says it has acquired Micron Technologies (Malvern, PA), a global provider...http://www.chemweek.com/chem_ideas/Guest-Author/Pharmafine-chemicals-roundup-26-March_50737.html March 22, 2013
“This is our last chance. If we don’t seize it, Japan will be left out,” declared Japanese Prime Minister Shinzo Abe in a televised address last Friday, calling for...http://www.chemweek.com/chem_ideas/Guest-Author/Three-reasons-US-chemical-manufacturers-would-welcome-Japan-to-TPP-negotiations_50698.html March 19, 2013
Mitsubishi Chemical subsidiary partners with Indian pharma ingredients firm Neuland Laboratories (Hyderabad, India), a pharmaceutical manufacturer providing active pharmaceutical...http://www.chemweek.com/chem_ideas/Guest-Author/Pharmafine-chemicals-roundup-19-March_50618.html March 13, 2013
Despite uncertainty stemming from the constant state of crisis imposed on the economy by the federal government, the general economy picked up steam during the latter part of last...http://www.chemweek.com/chem_ideas/Guest-Author/Specialty-chemical-manufacturers-cautiously-optimistic-about-2013_50479.html March 12, 2013
China to establish a more powerful food and drug safety watchdog The Chinese government says that it will elevate the status of the existing State Food and Drug Administration...http://www.chemweek.com/chem_ideas/Guest-Author/Pharmafine-chemicals-roundup-12-March_50438.html March 5, 2013
Siegfried reports huge rise in profits Siegfried (Zofingen, Switzerland), a producer of active pharmaceutical ingredients (APIs), intermediates, and finished drugs, reports a more than...http://www.chemweek.com/chem_ideas/Guest-Author/Pharmafine-chemicals-roundup-5-March_50253.html February 26, 2013
Informex 2013: Bright outlook for US API manufacturing Drug companies looking for speedy turnaround and strong intellectual property (IP) protection for active pharmaceutical...http://www.chemweek.com/chem_ideas/Guest-Author/Pharmafine-chemicals-roundup-26-February_50061.html February 19, 2013
Feature Pharma ingredients: Western manufacturers prepare for further expansion The active pharmaceutical ingredient industry will see further growth in the near term, and Western...http://www.chemweek.com/chem_ideas/Guest-Author/Pharmafine-chemicals-roundup-19-February_49933.html February 12, 2013
Teva’s API business reports rise in sales The active pharmaceutical ingredient (API) business of Teva Pharmaceutical (Petaḥ Tiqwa, Israel), recorded a 2.5% increase in sales in...http://www.chemweek.com/chem_ideas/Guest-Author/Pharmafine-chemicals-roundup-12-February_49761.html |
|
Connect with IHS Chemical Week |
Quick links |
Our related sites |
|
contact us | about us |
customer care |
privacy policy |
sitemap |
advertise
|